Pharmacological and biochemical evidence for the dopamine agonistic effect of bromocriptine.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000378:metabolism; D001971:Bromocriptine / Q000008:administration & dosage / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004876:Ergot Alkaloids / Q000494:pharmacology; D005260:Female; D013006:Growth Hormone / Q000378:metabolism; D006801:Humans; D008124:Locomotion / Q000187:drug effects; D007986:Luteinizing Hormone / Q000378:metabolism; D011247:Pregnancy; D011388:Prolactin / Q000378:metabolism; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects*; D012399:Rotation; D013239:Stereotyped Behavior / Q000187:drug effects
D004876:Ergot Alkaloids; D011954:Receptors, Dopamine; D001971:Bromocriptine; D011388:Prolactin; D007986:Luteinizing Hormone; D013006:Growth Hormone; D000262:Adenylyl Cyclases; D004298:Dopamine